Trivest-Advisors

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-08
Total Holdings
21
Total Value
1178885250
Accession Number
0000929638-25-001807
Form Type
13F-HR
Manager Name
Trivest-Advisors
Data Enrichment
90% identified
19 identified2 unidentified

Holdings

21 positions
Manager:
Search and click to pin securities to the top
Page 2 of 2
Summit Therapeutics Inc.
Shares:47.0K
Value:$906.6K